GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » Gross Profit

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Gross Profit : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is PD-RX Pharmaceuticals Gross Profit?

PD-RX Pharmaceuticals's gross profit for the three months ended in . 20 was $0.00 Mil. PD-RX Pharmaceuticals's gross profit for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. PD-RX Pharmaceuticals's gross profit for the three months ended in . 20 was $0.00 Mil. PD-RX Pharmaceuticals's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, PD-RX Pharmaceuticals's Gross Margin % for the quarter that ended in . 20 was N/A%.

PD-RX Pharmaceuticals had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


PD-RX Pharmaceuticals Gross Profit Historical Data

The historical data trend for PD-RX Pharmaceuticals's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PD-RX Pharmaceuticals Gross Profit Chart

PD-RX Pharmaceuticals Annual Data
Trend
Gross Profit

PD-RX Pharmaceuticals Quarterly Data
Gross Profit

Competitive Comparison of PD-RX Pharmaceuticals's Gross Profit

For the Medical Distribution subindustry, PD-RX Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PD-RX Pharmaceuticals's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PD-RX Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where PD-RX Pharmaceuticals's Gross Profit falls into.



PD-RX Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

PD-RX Pharmaceuticals's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

PD-RX Pharmaceuticals's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Gross Profit for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

PD-RX Pharmaceuticals's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PD-RX Pharmaceuticals  (OTCPK:PDRX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PD-RX Pharmaceuticals had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


PD-RX Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of PD-RX Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Headlines

From GuruFocus

PD-Rx Declares Dividend

By PRNewswire PRNewswire 05-07-2018

PD-Rx Declares Dividend

By PRNewswire PRNewswire 12-06-2018